Novo Holdings A/S Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$952.6B
Holdings
18
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTIVANGUARD INDEX FDS | 2,155,100 | $230.9B | 24.24% | |
| 2 | —OPHTHOTECH CORP | 3,610,487 | $184.2B | 19.34% | |
| 3 | INGNINOGEN INC | 3,549,320 | $177.9B | 18.67% | |
| 4 | VGKVANGUARD INTL EQUITY INDEX F | 2,101,000 | $98.0B | 10.29% | |
| 5 | RETAEURREATA PHARMACEUTICALS INC | 3,367,763 | $66.5B | 6.98% | |
| 6 | CRVSCORVUS PHARMACEUTICALS INC | 3,224,046 | $46.0B | 4.83% | |
| 7 | —TOBIRA THERAPEUTICS INC | 2,027,091 | $25.5B | 2.67% | |
| 8 | —COLUCID PHARMACEUTICALS INC | 3,056,563 | $25.0B | 2.62% | |
| 9 | XLRNACCELERON PHARMA INC | 685,863 | $23.3B | 2.45% | |
| 10 | —SPECTRANETICS CORP | 1,117,002 | $20.9B | 2.19% | |
| 11 | —FLEXION THERAPEUTICS INC | 950,161 | $14.2B | 1.49% | |
| 12 | MRUSMERUS N V | 1,410,417 | $11.3B | 1.18% | |
| 13 | —INVUITY INC | 1,075,448 | $10.2B | 1.08% | |
| 14 | —NABRIVA THERAPEUTICS AG | 1,054,823 | $7.9B | 0.83% | |
| 15 | —WRIGHT MED GROUP N V | 4,622,032 | $5.8B | 0.61% | |
| 16 | —HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $3.5B | 0.37% | |
| 17 | XENEXENON PHARMACEUTICALS INC | 127,563 | $753.0M | 0.08% | |
| 18 | —TOKAI PHARMACEUTICALS INC | 128,993 | $711.0M | 0.07% |